An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

A cervical cancer screening - which used to be known as a 'smear test' - is available for women and anyone with a cervix ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

Cervical cancer is the third most common gynecological cancer in the United States, but a Louisville doctor says it can be ...

Cervical cancer, one of the most common types of cancers, is mostly caused by HPV. Oncologist shares details on HPV and ...

The HPV vaccine offers protection against the most common high-risk HPV strains (16 and 18) as well as others that can cause ...

The self-test device that Mayo Clinic will use is the Evalyn Brush. The collection brush is housed inside a plastic tube, ...

Human papillomavirus (HPV) remains one of the most prevalent viral infections globally, affecting millions across ...

The Alabama Department of Public Health reports that there are 14,000 new HPV cases annually and 4,000 women die from the disease each year.

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.